State Ledger
Company profile

Trevi Therapeutics, Inc. CIK 1563880

Ticker
TRVI (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New Haven, CT 06510
Fiscal year end
2025 (FY)
Market Data
Close
$12.30
Change
-$0.64
Change %
-4.91%
Volume
134,394

TRVI · trading date Oct 13, 2026 · previous close $12.94 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$42.76M
Total assets
$193.44M
Total liabilities
$10.20M
Stockholders' equity
$183.24M
Cash & equivalents
$18.91M
Operating income
-$49.33M
Operating cash flow
-$42.09M
Capital expenditures
$12.0K

Fiscal year 2025, via 10-K filed 2026-03-17. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$42.10M
Free cash flow margin
—
Liabilities / assets
5.3%
Equity / assets
94.7%
CapEx / revenue
—
Operating cash flow / net income
0.98×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$42.76M $193.44M $10.20M $183.24M
2024 — -$47.91M $110.90M $11.26M $99.64M
2023 — -$29.07M $89.40M $6.86M $82.55M
2022 — -$29.15M $123.02M $15.56M $107.46M
2021 — -$33.94M $38.48M $21.40M $17.08M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-17

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New Haven, CT 06510
195 CHURCH STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:22 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Connecticut — Public Companies